Literature DB >> 28476576

Non-BMD DXA measurements of the hip.

Clinten P Edmondson1, Elliott N Schwartz2.   

Abstract

Hip fracture is one of the most serious complications of osteoporosis. More than 50% of hip and other fractures occur in patients without densitometric osteoporosis. Therefore, areal bone mineral density (aBMD) may not be the best way to assess fracture risk. In order to improve assessment of fracture risk, many other approaches have been taken. At the present time, the Fracture Risk Algorithm (FRAX©) is one of the most notable ways to improve assessment of fracture risk. However, since early in the initiation of the dual energy x-ray absorptiometry (DXA) era, several non-BMD DXA approaches to the assessment of hip fracture risk have been proposed. This review will cover some of those methodologies, including hip-axis length (HAL), hip-structural analysis (HSA), finite element analysis (FEA) by DXA, and body composition of the thigh by DXA (BCT). These methods have been utilized in models of hip fracture occurrence and in pharmacological clinical trials. How they should be used in clinical practice or if they should be used in clinical practice is more of an issue. In addition, we will discuss the recent proposal of the use of Long Femur Scan Field in the effort to diagnose atypical femoral fractures.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Atypical; Body composition; DXA; Femur; Finite element analysis; Fractures; Hip; Hip axis length; Hip structural analysis; Measurements; Non-BMD

Mesh:

Year:  2017        PMID: 28476576     DOI: 10.1016/j.bone.2017.03.050

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  4 in total

1.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2018-10-15       Impact factor: 4.507

2.  DXA evaluation of femoral bone mineral density and cortical width in patients with prior total knee arthroplasty.

Authors:  T Blaty; D Krueger; R Illgen; M Squire; B Heiderscheit; N Binkley; P Anderson
Journal:  Osteoporos Int       Date:  2018-08-31       Impact factor: 4.507

3.  Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome.

Authors:  N Tahani; L Nieddu; G Prossomariti; M Spaziani; S Granato; F Carlomagno; A Anzuini; A Lenzi; A F Radicioni; E Romagnoli
Journal:  Endocrine       Date:  2018-04-25       Impact factor: 3.633

4.  Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Authors:  Nasser Al-Daghri; Jaime C Branco; Olivier Bruyère; Loredana Cavalli; Cyrus Cooper; Bernard Cortet; Bess Dawson-Hughes; Hans Peter Dimai; Stefano Gonnelli; Peyman Hadji; Philippe Halbout; Jean-Marc Kaufman; Andreas Kurth; Medea Locquet; Stefania Maggi; Radmila Matijevic; Jean-Yves Reginster; René Rizzoli; Thomas Thierry; Adolfo Diez-Perez; Maria Luisa Brandi
Journal:  Aging Clin Exp Res       Date:  2019-08-17       Impact factor: 3.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.